View Item 

Show simple item record

Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency

dc.contributor.authorTaylor, J. R.en_US
dc.contributor.authorGardner, T. B.en_US
dc.contributor.authorWaljee, Akbar K.en_US
dc.contributor.authorDimagno, M. J.en_US
dc.contributor.authorSchoenfeld, Philip S.en_US
dc.date.accessioned2010-06-01T18:38:29Z
dc.date.available2010-06-01T18:38:29Z
dc.date.issued2010-01en_US
dc.identifier.citationTAYLOR, J. R.; GARDNER, T. B.; WALJEE, A. K.; DIMAGNO, M. J.; SCHOENFELD, P. S. (2010). "Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency." Alimentary Pharmacology & Therapeutics 31(1): 57-72. <http://hdl.handle.net/2027.42/71842>en_US
dc.identifier.issn0269-2813en_US
dc.identifier.issn1365-2036en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71842
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19804466&dopt=citationen_US
dc.format.extent144401 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2010 Blackwell Publishing Ltden_US
dc.titleSystematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiencyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationother† Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NHen_US
dc.contributor.affiliationother† VA Center for Excellence in Health Sciences Research, Ann Arbor, MIen_US
dc.identifier.pmid19804466en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71842/1/j.1365-2036.2009.04157.x.pdf
dc.identifier.doi10.1111/j.1365-2036.2009.04157.xen_US
dc.identifier.sourceAlimentary Pharmacology & Therapeuticsen_US
dc.identifier.citedreference1 Federal Register cited (69 82); Docket No. 2003N-0205. Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/04-9652.htm (accessed 25 October 2009).en_US
dc.identifier.citedreferenceWaljee AK, Dimagno MJ, Wu BU, Schoenfeld PS, Conwell DL. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther 2009; 29: 235 – 46.en_US
dc.identifier.citedreferenceFrancisco MP, Wagner MH, Sherman JM, Theriaque D, Bowser E, Novak DA. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 79 – 83.en_US
dc.identifier.citedreferenceBorowitz D, Konstan MW, O'Rourke A, Cohen M, Hendeles L, Murray FT. Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis. J Pediatr Pharmacol Ther 2007; 12: 47 – 52.en_US
dc.identifier.citedreferenceJadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1 – 12.en_US
dc.identifier.citedreferenceArmbrecht U, Svanvik J, StockbrÜgger R. Enzyme substitution in chronic pancreatitis: effects on clinical and functional parameters and on the hydrogen (H2) breath test. Scand J Gastroenterol Suppl 1986; 126: 55 – 9.en_US
dc.identifier.citedreferenceBeverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 1987; 62: 564 – 8.en_US
dc.identifier.citedreferenceBrady MS, Garson JL, Krug SK, et al. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. J Am Diet Assoc 2006; 106: 1181 – 6.en_US
dc.identifier.citedreferenceGullo L, Pezzilli A, Cassano A, Ligabue A, Ventrucci M. Clinical effectiveness of a new enteric-coated pancreatic enzyme extract in the treatment of pancreatic steatorrhea. Curr Ther Res 1988; 44: 105 – 9.en_US
dc.identifier.citedreferenceHalgreen H, Pedersen NT, Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 1986; 21: 104 – 8.en_US
dc.identifier.citedreferenceMarotta F, Girdwood AH, Marks IN, O’Keefe SJD, Young GO. Enteric-coated pancreatic enzyme supplementation. A dose-response study. Pathophysiology 1995; 2: 247 – 50.en_US
dc.identifier.citedreferenceMischler EH, Parrell S, Farrell PM, Odell GB. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Am J Dis Child 1982; 136: 1060 – 3.en_US
dc.identifier.citedreferenceMorrison G, Morrison JM, Redmond AO, et al. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther 1992; 6: 549 – 55.en_US
dc.identifier.citedreferenceOpekun AR Jr, Sutton FM Jr, Graham DY. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults. Aliment Pharmacol Ther 1997; 11: 981 – 6.en_US
dc.identifier.citedreferenceParis JC. A multicentre double-blind placebo-controlled study of the effect of a pancreatic enzyme formulation (Panzytrat 25000) on impaired lipid digestion in adults with chronic pancreatitis. Drug Investig 1993; 5: 229 – 37.en_US
dc.identifier.citedreferencePasquali C, Fogar P, Sperti C, Basso D. Efficacy of a pancreatic enzyme formulation in the treatment of steatorrhea in patients with chronic pancreatitis. Curr Ther Res 1996; 57: 358 – 65.en_US
dc.identifier.citedreferencePatchell CJ, Desai M, Weller PH, et al. Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheres – an open randomised crossover preference study. J Cyst Fibros 2002; 1: 287 – 91.en_US
dc.identifier.citedreferenceRobinson PJ, Olinsky A, Smith AL, Chitravanshi SB. High compared with standard dose lipase pancreatic supplement. Arch Dis Child 1989; 64: 143 – 5.en_US
dc.identifier.citedreferenceShah A, Dinwiddie R, Madge S, Prescott P, Hudson G. High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr 1993; 152: 763 – 4.en_US
dc.identifier.citedreferenceThomson M, Clague A, Cleghorn GJ, Shepherd RW. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency. J Pediatr Gastroenterol Nutr 1993; 17: 407 – 13.en_US
dc.identifier.citedreferenceVantini I, Fioretta A, Caliari S, Benini L, Brentegani MT, Castellani G. Effects of two pancreatic enzyme-containing enteric-coated microsphere preparations on steatorrhea in chronic alcoholic pancreatitis. Curr Ther Res 1990; 48: 268 – 74.en_US
dc.identifier.citedreferenceVyas H, Matthew DJ, Milla PJ. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. Eur J Pediatr 1990; 149: 241 – 3.en_US
dc.identifier.citedreferenceBowler IM, Wolfe SP, Owens HM, Sheldon TA, Littlewood JM, Walters MP. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child 1993; 68: 227 – 30.en_US
dc.identifier.citedreferenceDelchier JC, Vidon N, Saint-Marc Girardin MF, et al. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations. Aliment Pharmacol Ther 1991; 5: 365 – 78.en_US
dc.identifier.citedreferenceDelhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Eur J Gastroenterol Hepatol 1996; 8: 699 – 703.en_US
dc.identifier.citedreferenceDutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 1983; 84: 476 – 82.en_US
dc.identifier.citedreferenceGan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Aliment Pharmacol Ther 1994; 8: 603 – 7.en_US
dc.identifier.citedreferenceGouerou H, Dain MP, Parrondo I, Poisson D, Bernades P. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study. Int J Pancreatol 1989; 5: 45 – 50.en_US
dc.identifier.citedreferenceHalm U, Loser C, Lohr M, Katschinski M, Mossner J. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther 1999; 13: 951 – 7.en_US
dc.identifier.citedreferenceKalnins D, Ellis L, Corey M, et al. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006; 42: 256 – 61.en_US
dc.identifier.citedreferenceKonstan MW, Stern RC, Trout JR, et al. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy. Aliment Pharmacol Ther 2004; 20: 1365 – 71.en_US
dc.identifier.citedreferenceLancellotti L, Cabrini G, Zanolla L, Mastella G. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial. J Pediatr Gastroenterol Nutr 1996; 22: 73 – 8.en_US
dc.identifier.citedreferenceSantini B, Antonelli M, Battistini A, et al. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Dig Liver Dis 2000; 32: 406 – 11.en_US
dc.identifier.citedreferenceWilliams J, MacDonald A, Weller PH, Fields J, Pandov H. Two enteric coated microspheres in cystic fibrosis. Arch Dis Child 1990; 65: 594 – 7.en_US
dc.identifier.citedreferenceDiMagno EP. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. Best Pract Res Clin Gastroenterol 2001; 15: 477 – 86.en_US
dc.identifier.citedreferenceSafdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 156 – 62.en_US
dc.identifier.citedreferenceYadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169: 1035 – 45.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2036.2009.04157.x.pdf
Size:
141.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.